As radiopharmaceutical therapy (RPT) expands beyond neuroendocrine tumors and prostate cancer, it is important to understand ...
Bone metastases are common, especially in more prevalent malignancies such as breast and prostate cancer. They cause significant morbidity and draw on health-care resources. Molecular and hybrid ...
In vivo pretargeting stands as a promising approach to harnessing the exquisite tumor-targeting properties of antibodies for nuclear imaging and therapy while simultaneously skirting their ...
We developed a new C-X-C chemokine receptor 4 (CXCR4)–targeting radiolabeled peptide, [68Ga]Ga/[177Lu]Lu-BL34, using a novel and potent cyclic peptide based on structure–activity relationship studies ...
Prostate-specific membrane antigen (PSMA) PET is a well-established imaging tool for the evaluation of primary and recurrent prostate cancer (PCa). 177 Lu PSMA-targeted radiopharmaceutical therapy ...
Journal of Nuclear Medicine June 2026, jnumed.126.272009; DOI: https://doi.org/10.2967/jnumed.126.272009 ...
Nectin-4 is an overexpressed biomarker in 60%–70% of triple-negative breast cancer (TNBC) cases and an ideal target for radiotherapy and PET imaging. In this study, theranostic radioimmunoconjugates ...
In this paper, we present the approach that we have developed to design a pragmatic, robust testing system for SPECT and PET imaging validation that does not require unique expertise in phantom ...
Actinomycosis is a rare gram-positive infection, generally granulomatous. The diagnosis can be complex and sometimes can be achieved only at the chronic stage. Actinomyces normally colonize the mouth, ...
Journal of Nuclear Medicine June 2026, jnumed.125.271856; DOI: https://doi.org/10.2967/jnumed.125.271856 ...
The coronavirus 2019 (COVID-19) pandemic has changed our personal and professional life (1). It has affected the workflow in nuclear medicine departments (2). Imaging findings of COVID-19 in the acute ...
Overall Survival with [177 Lu]Lu-PSMA-617 Versus [177 Lu]Lu-PSMA I&T: A Propensity Score–Matched Real-World Analysis ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results